Lantern Pharma (LTRN) Price-to-Earnings (P/E) Ratio

Price: $3.8
Market Cap: $40.98M
Avg Volume: 94.03K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.632
52W Range: $2.79-11.99
Website: Lantern Pharma

Price-to-Earnings (P/E) Ratio Summary

Lantern Pharma's P/E ratios across different time periods:

  • TTM: -2.14
  • Annual: -2.91
  • Quarterly: -2.19

What is P/E Ratio?

The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.

Related Metrics

  • Price-to-Book (P/B) Ratio: 1.13
  • Price-to-Sales (P/S) Ratio: 0.00

Annual Ratios

Lantern Pharma Historical P/E Ratio

Historical P/B Ratio

Historical P/S Ratio

TTM P/E Ratio

-2.14

P/B Ratio (Annual)

1.13

P/S Ratio (Annual)

0.00

Lantern Pharma Historical Valuation Metrics

The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2023.

Year P/E Ratio P/B Ratio P/S Ratio
2023 -2.91 1.13 0.00
2022 -4.65 1.17 0.00
2021 -7.08 1.22 0.00
2020 -20.27 6.08 0.00
2019 -38.57 99.29 0.00
2018 -53.84 -460.62 0.00

Related Metrics

Explore detailed financial metrics and analysis for LTRN.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio